Dashboard
Manage Tickers

YHOOALTABA INC.

Nasdaq www.yahoo.com


$ 19.48 $ 0.00 (0 %)    

Monday, 30-Sep-2019 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 19.63
$ 19.62 x 1,300
$ 19.70 x 300
-- - --
$ 19.25 - $ 79.18
48,010,479
na
18.91B
$ 1.42
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2017 03-31-2017 10-Q
2 03-01-2017 12-31-2016 10-K
3 11-09-2016 09-30-2016 10-Q
4 08-08-2016 06-30-2016 10-Q
5 05-10-2016 03-31-2016 10-Q
6 02-29-2016 12-31-2015 10-K
7 11-05-2015 09-30-2015 10-Q
8 08-07-2015 06-30-2015 10-Q
9 05-07-2015 03-31-2015 10-Q
10 02-27-2015 12-31-2014 10-K
11 11-07-2014 09-30-2014 10-Q
12 08-07-2014 06-30-2014 10-Q
13 05-08-2014 03-31-2014 10-Q
14 02-28-2014 12-31-2013 10-K
15 11-12-2013 09-30-2013 10-Q
16 08-08-2013 06-30-2013 10-Q
17 05-07-2013 03-31-2013 10-Q
18 03-01-2013 12-31-2012 10-K
19 11-08-2012 09-30-2012 10-Q
20 08-09-2012 06-30-2012 10-Q
21 05-09-2012 03-31-2012 10-Q
22 02-29-2012 12-31-2011 10-K
23 11-07-2011 09-30-2011 10-Q
24 08-08-2011 06-30-2011 10-Q
25 05-10-2011 03-31-2011 10-Q
26 02-28-2011 12-31-2010 10-K
27 11-08-2010 09-30-2010 10-Q
28 08-09-2010 06-30-2010 10-Q
29 05-10-2010 03-31-2010 10-Q
30 02-26-2010 12-31-2009 10-K
31 11-06-2009 09-30-2009 10-Q
32 08-07-2009 06-30-2009 10-Q
33 05-08-2009 03-31-2009 10-Q
34 02-27-2009 12-31-2008 10-K
35 11-07-2008 09-30-2008 10-Q
36 08-08-2008 06-30-2008 10-Q
37 05-08-2008 03-31-2008 10-Q
38 02-27-2008 12-31-2007 10-K
39 11-09-2007 09-30-2007 10-Q
40 08-08-2007 06-30-2007 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION